Clin2
NCT07241546Possibly a fitRecruiting

Inhaled study drug for people with mild allergic asthma

Asthma

Part of Immune system & allergy, Lungs & breathing clinical trials.

This trial tests an inhaled drug called ARO-RAGE to see if it can help people with mild asthma who have allergies. You'll take the drug and then do a special breathing test to see how your lungs respond.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
36 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have mild asthma that is stable and controlled
  • You have allergies confirmed by a skin test
  • You can do breathing tests like spirometry
  • If you could become pregnant, you agree to use highly-effective birth control plus a condom during the study and for 90 days after
  • You do not have other serious lung diseases besides asthma

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07746687Not yet recruiting· Phase 2
Study of an experimental pill for uncontrolled moderate to severe asthma

This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.

NCT07851623Recruiting· Phase 1
Inhaled study drug for healthy adults and adults with asthma

This early-phase study tests an inhaled medication (CHF10136) to see if it's safe and how the body handles it. It includes both healthy adults and people with asthma, and participants will be monitored closely throughout.

Leeds
NCT06977581Recruiting· Phase 2
Study of PF-07275315 for moderate-to-severe asthma

This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.

Mobile, Alabama
NCT07772921Recruiting· Phase 3
New study medicine for severe asthma

This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.

Bakersfield, California
NCT06224634Recruiting
Testing a new drug for airway problems

This trial tests how a drug called anti-IL-17 affects your airways. If you are already planning to take this drug, researchers want to see if it helps with breathing and airway resistance.

Hvidovre, Capital Region
NCT07780643Recruiting· Phase 3
Asthma study for uncontrolled asthma on inhaled steroids

This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.

Miami Lakes, Florida

Hear when a new Asthma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.